CTRI/2023/07/055796尚未招募2 期
Evaluation of safety and efficacy of Zaranbad (Curcuma zedoaria Rosc.) in Primary hypertension- a randomized standard control trial. - NI
uqman Unani Medical College Hospital and Research Center0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Diagnosed cases of grade1 hypertension
排除标准
- •Pregnant and lactating women.
- •Patients suffering from any other systemic diseases.
- •Patients suffering from secondary hypertension
研究者
相似试验
招募中
2 期
Effect of Chandraprabha Vati along with Gokshuradi Guggulu in patients of Benign Prostatic Hyperplasia (BPH)CTRI/2023/06/053971Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Goverment of India
尚未招募
1 期
BICICL: BTK and Immune Checkpoint Inhibitor in Central Nervous System (CNS) LymphomaCentral Nervous System LymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaACTRN12622000547741Monash University30
尚未招募
2 期
Assessment of safety and efficacy of KabasuraKudineer in mild to moderate COVID-19CTRI/2020/08/026985Chettinad Hospital and Research Institute
尚未招募
2 期
Application of Sarjarasa Malahara(Ointment) in the management of Padadari (CRACK HEEL)CTRI/2023/05/052289CCRAS
进行中（未招募）
1 期
A study to look at the safety and success of using Clazakizumab in patients who have kidney disease and COVID-19.EUCTR2020-002476-13-GBImperial College London20